Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! 

China Clinical Trials 2017

Analysis of IND and NDA applications and approvals in China 2011-2017

Download free report on life science investment in China

3SBio and DaVita Announce $20 Million Dialysis JV for China

publication date: Mar 9, 2012
3SBio will form a $20 million JV with DaVita Inc., a US-based company that owns and operates kidney dialysis clinics. The JV will provide dialysis services to Jilin and Liaoning provinces in northeast China. DaVita will contribute 70% of the start-up capital and 3SBio will be responsible for the remainder. As part of the agreement, the JV will use 3SBio’s EPAIO, a recombinant human erythropoietin, to treat the anemia that is often a side-effect of dialysis. More details....

Stock Symbols: (NSDQ: SSRX) (NYSE: DVA)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Events
The 9th China Healthcare Investment Conference
Shanghai, China
March 27-29, 2018
Use chinabio18 for 20% discount